Envestnet Asset Management
KERX

Envestnet Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Envestnet Asset Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,076
Closed -$57K – 3123
2015
Q3 		$57K Sell
16,076
-3,365
-17% -$22.5K ﹤0.01% 2590
2015
Q2 		$194K Buy
19,441
+4,784
+33% +$51.3K ﹤0.01% 2143
2015
Q1 		$187K Buy
+14,657
New +$188K ﹤0.01% 1970
2014
Q1 		– Sell
-63
Closed -$1K – 2684
2013
Q4 		$1K Buy
+63
New +$752 ﹤0.01% 2411

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Envestnet Asset Management's KERX Position: Q4 2015 in Review

Envestnet Asset Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2015, closing a stake of 16,076 shares — an estimated $57K sold.

Envestnet Asset Management first reported a position in KERX in Q4 2013 and held it in 4 quarters. The position peaked at $194K in Q2 2015. 128 funds tracked by Wall St. Rank hold KERX as of Q4 2015.

  • Envestnet Asset Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Envestnet Asset Management sold 16,076 Keryx Biopharmaceuticals Inc shares in Q4 2015, an estimated $57K.
  • Envestnet Asset Management first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 4 quarters.
  • Envestnet Asset Management's Keryx Biopharmaceuticals Inc position peaked at $194K in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2015.

Based on Envestnet Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.